Valeant Pharmaceuticals v. Actavis Laboratories Fl., Inc

U.S. Court of Appeals for the Federal Circuit

Valeant Pharmaceuticals v. Actavis Laboratories Fl., Inc

Opinion

Case: 20-1201 Document: 54 Page: 1 Filed: 12/18/2020

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

VALEANT PHARMACEUTICALS INTERNATIONAL, SALIX PHARMACEUTICALS LTD., COSMO TECHNOLOGIES LIMITED, Plaintiffs-Appellants

v.

ACTAVIS LABORATORIES FL., INC., ACTAVIS PHARMA, INC., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD., Defendants-Appellees ______________________

2020-1201 ______________________

Appeal from the United States District Court for the District of Delaware in No. 1:18-cv-01288-LPS, Chief Judge Leonard P. Stark. ______________________

JUDGMENT ______________________

THOMAS P. STEINDLER, McDermott, Will & Emery LLP, Washington, DC, argued for all plaintiffs-appellants. Plaintiffs-appellants Valeant Pharmaceuticals Interna- tional, Salix Pharmaceuticals Ltd. also represented by CHRISTOPHER MICHAEL BRUNO, PAUL MICHAEL Case: 20-1201 Document: 54 Page: 2 Filed: 12/18/2020

SCHOENHARD.

GARY N. FRISCHLING, Milbank LLP, Los Angeles, CA, for plaintiff-appellant Cosmo Technologies Limited. Also represented by YITE JOHN LU.

WILLIAM M. JAY, Goodwin Procter LLP, Washington, DC, argued for defendants-appellees. Also represented by JOHN T. BENNETT, GERARD JUSTIN CEDRONE, SAMUEL SHERRY, Boston, MA; ELIZABETH HOLLAND, New York, NY. ______________________

THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (NEWMAN, DYK, and REYNA, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

December 18, 2020 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court

Reference

Status
Unpublished